Sensitization of slow pressor angiotensin II (Ang II)-initiated hypertension: Induction of sensitization by prior Ang II treatment

Hypertension

Volumn 59, Issue 2 SUPPL. 1, 2012, Pages 459-466

  Xue, Baojian ^a   Zhang, Zhongming ^a   Johnson, Ralph F ^a   Johnson, Alan Kim ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

angiotensin II; blood pressure; neuronal activation; RAAS component expression; sensitization

Indexed keywords

ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN II; MESSENGER RNA; PROTEIN FOS;

ANIMAL EXPERIMENT; ANIMAL TISSUE; BLOOD PRESSURE MEASUREMENT; CONFERENCE PAPER; EXPERIMENTAL DESIGN; FOREBRAIN; HYPERTENSION; IMMUNOREACTIVITY; LOW DRUG DOSE; NONHUMAN; PRIORITY JOURNAL; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SENSITIZATION; ANIMAL MODEL; BLOOD PRESSURE; BRAIN TISSUE; DRUG METABOLISM; DRUG SENSITIZATION; GENE EXPRESSION; MALE; SPRAGUE DAWLEY RAT; ANIMAL; ARTICLE; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECT; HEART RATE; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; SUBCUTANEOUS DRUG ADMINISTRATION;

ANGIOTENSIN II; ANIMALS; BLOOD PRESSURE; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HEART RATE; HYPERTENSION; INJECTIONS, INTRAVENTRICULAR; INJECTIONS, SUBCUTANEOUS; MALE; RATS; RATS, SPRAGUE-DAWLEY; RENIN-ANGIOTENSIN SYSTEM; RNA, MESSENGER;

EID: 84856090864     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.111.185116     Document Type: Conference Paper

References (38)

1. Dickinson DM, Lawrence JR, Adelaide MB. A slowly developing pressor response to small concentrations of angiotensin its bearing on the pathogenesis of chronic renal hypertension. Lancet. 1963;281: 1354-1356.
2. Dickinson CJ, Yu R. The progressive pressor response to angiotensin in the rabbit. J Physiol. 1967;190:91-99.
3. Bohr DF. Angiotensin on vascular smooth muscle. In: Page IH and Bumpus FM, eds. Angiotensin. New York, NY: Springer-Verlag; 1965: 424-440.
4. Simon G, Abraham G, Cserep G. Pressor and subpressor angiotensin II administration: Two experimental models of hypertension. Am J Hypertens. 1995;8:645-650.
5. Sakai RR, Fine WB, Epstein AN, Frankmann SP. Salt appetite is enhanced by one prior episode of sodium depletion in the rat. Behav Neurosci. 1987;101:724-731. (Pubitemid 18045113)
6. Moellenhoff E, Blume A, Culman J, Chatterjee B, Herdegen T, Lebrun C, Unger T. Effect of repetitive icv injections of ANG II on c-Fos and AT1-receptor expression in the rat brain. Am J Physiol Regul Integr Comp Physiol. 2001;280:R1095-R1104.
7. Gao L, Zucker IH. AT2 receptor signaling and sympathetic regulation. Curr Opin Pharmacol. 2011;11:124-130.
8. Xu P, Sriramula S, Lazartigues E. ACE2/ANG-(1-7)/Mas pathway in the brain: The axis of good. Am J Physiol Regul Integr Comp Physiol. 2011;300:R804-R817.
9. Lavoie JL, Sigmund CD. Minireview: Overview of the renin-angiotensin system: An endocrine and paracrine system. Endocrinology. 2003;144: 2179-2183. (Pubitemid 36629863)
10. Coppo M, Bandinelli M, Berni A, Galastri S, Abbate R, Poggesi L, Marra F, Gensini GF, Boddi M. Ang II Upregulation of the T-lymphocyte renin-angiotensin system is amplified by low-grade inflammation in human hypertension. Am J Hypertens. 2011;24:716-723.
11. Gonzalez-Villalobos RA, Satou R, Ohashi N, Semprun-Prieto LC, Katsurada A, Kim C, Upchurch GM, Prieto MC, Kobori H, Navar LG. Intrarenal mouse renin-angiotensin system during Ang II-induced hypertension and ACE inhibition. Am J Physiol Renal Physiol. 2010;298: F150-F157.
12. Porter JP. Chronic intracerebroventricular infusion of angiotensin II increases brain AT1 receptor expression in young rats. Dev Brain Res. 1999;112:293-295. (Pubitemid 29083275)
13. Wei SG, Yu Y, Zhang ZH, Felder RB. Angiotensin II upregulates hypothalamic AT1 receptor expression in rats via the mitogen-activated protein kinase pathway. Am J Physiol Heart Circ Physiol. 2008;296: H1425-H1433.
14. Xue B, Beltz TG, Yu Y, Guo F, Gomez-Sanchez CE, Hay M, Johnson AK. Central interactions of aldosterone and angiotensin II in aldosteroneand angiotensin-induced hypertension. Am J Physiol Heart Circ Physiol. 2011;300:H555-H564.
15. Vieira AA, Nahey DB, Collister JP. Role of the organum vasculosum of the lamina terminalis for the chronic cardiovascular effects produced by endogenous and exogenous ANG II in conscious rats. Am J Physiol Regul Integr Comp Physiol. 2010;299:R1564-R1571.
16. Crowley SD, Gurley SB, Herrera MJ, Ruiz P, Griffiths R, Kumar AP, Kim HS, Smithies O, Le TH, Coffman TM. Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney. Proc Natl Acad Sci U S A. 2006;103:17985-17990. (Pubitemid 44852272)
17. Gorbea-Oppliger VJ, Melaragno MG, Potter GS, Petit RL, Fink GD. Time course of losartan blockade of angiotensin II hypertension versus blockade of angiotensin II fast pressor effects. J Pharmacol Exp Ther. 1994;271:804-810. (Pubitemid 24377768)
18. Cox BF, Bishop VS. Neural and humoral mechanisms of angiotensindependent hypertension. Am J Physiol. 1991;261:H1284-H1291.
19. Johnson AK, Gross PM. Sensory circumventricular organs and brain homeostatic pathways. FASEB J. 1993;7:678-686. (Pubitemid 23163603)
20. Davern PJ, Head GA. Fos-related antigen immunoreactivity after acute and chronic angiotensin II-induced hypertension in the rabbit brain. Hypertension. 2007;49:1170-1177. (Pubitemid 351664323)
21. Huang BS, Ahmadi S, Ahmad M, White RA, Leenen FH. Central neuronal activation and pressor responses induced by circulating ANG II: Role of the brain aldosterone-"ouabain" pathway. Am J Physiol Heart Circ Physiol. 2010;299:H422-H430.
22. Imboden H, Harding JW, Hilgenfeldt U, Celio MR, Felix D. Localization of angiotensinogen in multiple cell types of rat brain. Brain Res. 1987; 410:74-77. (Pubitemid 17075183)
23. Fuxe K, Ganten D, Hökfelt T, Locatelli V, Poulsen K, Stock G, Rix E, Taugner R. Renin-like immunocytochemical activity in the rat and mouse brain. Neurosci Lett. 1980;18:245-250. (Pubitemid 11233418)
24. Sakai K, Agassandian K, Morimoto S, Sinnayah P, Cassell MD, Davisson RL, Sigmund CD. Local production of angiotensin II in the subfornical organ causes elevated drinking. J Clin Invest. 2007;117: 1088-1095. (Pubitemid 46556765)
25. Masaki H, Kurihara T, Yamaki A, Inomata N, Nozawa Y, Mori Y, Murasawa S, Kizima K, Maruyama K, Horiuchi M, Dzau VJ, Takahashi H, Iwasaka T, Inada M, and Matsubara H. Cardiac-specific overexpression of angiotensin II AT2 receptor causes attenuated response to AT1 receptor-mediated pressor and chronotropic effects. J Clin Invest. 1998; 101:527-535. (Pubitemid 28084234)
26. Yu L, Zheng M, Wang W, Rozanski GJ, Zucker IH, Gao L. Developmental changes in AT1 and AT2 receptor-protein expression in rats. J Renin Angiotensin Aldosterone Syst. 2011;11:214-221.
27. Gao J, Zhang H, Le KD, Chao J, Gao L. Activation of central angiotensin type 2 receptors suppresses norepinephrine excretion and blood pressure in conscious rats. Am J Hypertens. 2011;24:724-730.
28. Gao L, Wang W, Wang W, Li H, Sumners C, Zucker IH. Effects of angiotensin type 2 receptor overexpression in the rostral ventrolateral medulla on blood pressure and urine excretion in normal rats. Hypertension. 2008;51:521-527. (Pubitemid 351156442)
29. Gao L, Wang WZ, Wang W, Zucker IH. Imbalance of angiotensin type 1 receptor and angiotensin II type 2 receptor in the rostral ventrolateral medulla: Potential mechanism for sympathetic overactivity in heart failure. Hypertension. 2008;52:708-714.
30. Peng JF, Phillips MI. Opposite regulation of brain angiotensin type 1 and type 2 receptors in cold-induced hypertension. Regul Pept. 2001;97: 91-102. (Pubitemid 32119510)
31. Siddiqui AH, Ali Q, Hussain T. Protective role of angiotensin II subtype 2 receptor in blood pressure increase in obese Zucker rats. Hypertension. 2009;53:256-261.
32. Guimarães PB, Alvarenga É C, Siqueira PD, Paredes-Gamero EJ, Martin RP, Shimuta SI, Carmona AK, Nakaie CR, Jasiulionis MG, Ferreira AT, Pesquero JL, Oliveira SM, Bader M, Costa-Neto CM, Pesquero JB. Angiotensin II binding to angiotensin I-converting enzyme triggers calcium signaling. Hypertension. 2011;57:965-972.
33. Ferrario CM. Angiotensin-converting enzyme 2 and angiotensin-(1-7): An evolving story in cardiovascular regulation. Hypertension. 2006;47: 515-521. (Pubitemid 43843868)
34. Xia H, Feng Y, Obr TD, Hickman PJ, Lazartigues E. Angiotensin II type 1 receptor-mediated reduction of angiotensin-converting enzyme 2 activity in the brain impairs baroreflex function in hypertensive mice. Hypertension. 2009;53:210-216.
35. Feng Y, Xia H, Cai Y, Halabi CM, Becker LK, Santos RA, Speth RC, Sigmund CD, Lazartigues E. Brain-selective overexpression of human Angiotensin- converting enzyme type 2 attenuates neurogenic hypertension. Circ Res. 2010;106:373-382.
36. Funder JW, Mihailidou AS. Aldosterone and mineralocorticoid receptors: Clinical studies and basic biology. Mol Cell Endocrinol. 2009; 301:2-6.
37. Gomez-Sanchez CE, Zhou MY, Cozza EN, Morita H, Foecking MF, Gomez-Sanchez EP. Aldosterone biosynthesis in the rat brain. Endocrinology. 1997;138:3369-3373. (Pubitemid 27345690)
38. Fiebeler A, Nussberger J, Shagdarsuren E, Rong S, Hilfenhaus G, Al-Saadi N, Dechend R, Wellner M, Meiners S, Maser-Gluth C, Jeng AY, Webb RL, Luft FC, Muller DN. Aldosterone synthase inhibitor ameliorates angiotensin II-induced organ damage. Circulation. 2005;111: 3087-3094. (Pubitemid 40847786)